美洛西林联合微生态制剂对感染性腹泻患儿的临床观察  

Clinical observation of mezlocillin combined with probiotics in the treatment of children with infectious diarrhea

作　　者：向昌龙[1] 伍国典[1] Xiang Changlong,Wu Guodian(The People＇s Hospital of Hanshou County 41590)

机构地区：[1]汉寿县人民医院,415900

出　　处：《中国社区医师》2018年第16期76-77,共2页Chinese Community Doctors

摘　　要：目的:观察美洛西林联合微生态制剂对感染性腹泻患儿的临床效果。方法:收治感染性腹泻患儿88例,平分两组。对照组采纳美洛西林治疗,在此基础上,研究组采用微生态制剂联合治疗。比较两组治疗效果、临床症状改善情况。结果:与对照组比较,研究组治疗效果较高;与对照组比较,研究组大便、体温恢复正常时间以及腹泻消失时间较短,差异均有统计学意义(P<0.05)。结论:微生态制剂与美洛西林联合可有效改善感染性腹泻患儿的临床症状,促进机体恢复,效果确切。Objective：To observe the clinical effect of mezlocillin combined with probiotics in the treatment of children with infectious diarrhea.Methods：88 children with infectious diarrhea were selected.They were randomly divided into the two groups on average.The control group adopted the treatment of mezlocillin.On this basis,the study group adopted the combined treatment of microecological agents.We compared the therapeutic effects and improvement of clinical symptoms.Results：Compared with the control group,the treatment effect of the study group was higher.Stool,temperature recovery time and diarrhea disappearance time were compared with the control group,the study group was shorter,and the differences were statistically significant（P〈0.05）.Conclusion：Probiotics and mezlocillin combination can effectively improve the clinical symptoms of infectious diarrhea,promote the body recovery,which has the exact effect.

关 键 词：美洛西林 微生态制剂 感染性腹泻 

分 类 号：R725.7[医药卫生—儿科]